EMMAC is bringing together the latest science and research into the medical benefits of cannabis with pioneering cultivation, extraction and production to establish itself as the European leader in the production and supply of medical cannabis.
EMMAC is at the forefront of the global medical cannabis industry working with research institutions to deliver clinical data regarding the efficacy of medical cannabis for pain and the potential public health benefits for patients.
EMMAC announces pioneering research collaboration with Imperial College London
The partnership between EMMAC and Imperial College London has been forged to deliver a long-term comprehensive research programme designed to shape the future of the medical cannabis therapeutic industry.
EMMAC’s European Operations
EMMAC has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also a European leader in the production and supply of medical cannabis, hemp and other derivative products.
EMMAC Across Europe
Events & Press Releases
For more information, visit: https://www.theemeraldconference.com
Medalchemy, EMMAC’s Spanish GMP certified laboratory, secures approval to import medical cannabis for scientific research
19 March 2019, London: EMMAC, the European independent medical cannabis company, is pleased to announce that Medalchemy, EMMAC’s fully-licensed GMP certified laboratory in Alicante, Spain, has secured approval fromRead more »
EMMAC is pleased to announce that the Company will be presenting collaborative work with Imperial College at the 5th International Emerald Conference in San Diego on the 28th of February.Read more »